Last kr108.00 SEK
Change Today -0.30 / -0.28%
Volume 244.9K
MEDAA On Other Exchanges
Symbol
Exchange
OTC US
Stockholm
Berlin
OTC US
As of 11:29 AM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Lennart Perlhagen

Former Director, Meda AB
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 2 different industries.

See Board Relationships
72--

Background*

Lennart Perlhagen served as Chief Executive Officer for Scandinavia and UK for Pfizer where Mr. Perlhagen gained extensive experience in oncology through the launch of the chemotherapy agent doxorubicin (Adriamycin). Mr. Perlhagen helped lead the commercial launch of omeprazole (Losec/ Prilosec), which became the best selling pharmaceutical product in the world for AstroZeneca AB where he served as Regional Director for South Europe. He founded Meda AB. He has been a ...

Read Full Background

Corporate Headquarters*

Pipers väg 2A
Solna, Stockholm County 170 73

Sweden

Phone: 46 86 30 19 00
Fax: 46 86 30 19 50

Board Members Memberships*

Director
1999-N/A
Former Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MEDAA:SS kr108.00 SEK -0.30

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
SFr.2.6M
Marc M.P. de Garidel Chairman, Chief Executive Officer and Member of Strategic Committee
Ipsen S.A.
€1.4M
Giovanni Recordati Chairman, Chief Executive Officer and General Manager
Recordati SpA
€1.4M
Eduardo Javier Sanchiz Yrazu Chief Executive Officer, Member of Management Board, Chief Executive of Corporate Development & Finance, Executive Director and Member of Compliance Committee
Almirall, S.A.
--
Timo Lappalainen M.Sc. (Ind. Eng.)Chairman of the Executive Management Board, Chief Executive Officer and President
Orion Oyj
€1.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDA AB-A SHS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.